DrugPatentWatch Database Preview
Litigation Details for Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)
| Docket | Start Trial | Date Filed | 2011-08-18 |
| Court | District Court, D. Delaware | Date Terminated | 2013-11-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | CADENCE PHARMACEUTICALS INC.; EXELA HOLDINGS INC.; EXELA PHARMA SCIENCES LLC; EXELA PHARMSCI INC.; PADDOCK LABORATORIES INC.; PADDOCK LABORATORIES LLC; PERRIGO COMPANY; SCR PHARMATOP | ||
| Patents | 6,028,222; 6,992,218 | ||
| Attorneys | Adam Wyatt Poff; Jack B. Blumenfeld; Richard L. Horwitz; Robert J. Katzenstein; Thomas C. Grimm | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC
The small molecule drug covered by the patents cited in this case is Start Trial .
Details for Cadence Pharmaceuticals Inc. v. Exela Pharma Sciences LLC (D. Del. 2011)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2012-08-22 | 188 | terms found in U.S. Patent Nos. 6,028,222 (the '"222 patent") and 6,992,218 (the …the "'218 patent") ~ I (collectively, the "patents-in-suit"). l I. …alleging infringement of ~ i the patents-in-suit. (D.I. 1) The patents-in-suit relate to formulations and…acetaminophen. (See '222 patent col.l8 11.50-55) The '218 patent relates to an "extreme…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which | External link to document | |
| 2012-10-01 | 225 | Plaintiffs allege infringement of U.S. Patent Nos. 6,028,222 and 6,99 ,218 as a result of an Abbreviated… 6. "Patent misuse is an affirmative defen e to an accusation of patent infringement, …Filing of al suit for patent infringement can constitute I ~ patent misuse if the suit was…#39;a claim of a patent is invalid,"' but "an issued patent is presu ed valid,"… "Plaintiffs") filed this action for patent infringement gainst Paddock Laboratories, Inc.; | External link to document | |
| 2012-10-04 | 231 | infringement of U.S. Patent Nos. 6,028,222 (the ’222 patent) and 6,992,218 (the ’21 8 patent) under 35 U.S.C…rights in the patents-in-suit. Plaintiff SCR Pharmatop, the patent owner, licensed the patents to BMS. BMS…sublicensed the patents to plaintiff Cadence but BMS retained substantial rights in the patents _ Th@r€f@r@… “ALL SUBSTANTIAL RIGHTS” IN THE PATENTS Standing to bring a patent suit is a question of subject matter… of the patent, such that the exclusive licensee holds “all substantial rights” in the patent. Alfr" | External link to document | |
| 2012-10-24 | 249 | 8. The term “the Patents~in-Suit” means U.S. Patent No. 6,028,222 and U.S. Patent No. 6,992,218, collectively…Paddook”);_ WHEREAS, Plaintiffs suedPaddocl< for patent infringement based on Paddock’s filing of ANDA…concerning the use of any information set forth in the Patents- in-Suit during the development of the Paddock … 22 November 2013 1:11-cv-00733-LPS Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
